Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.
Neuroinflammation preceding and accompanying primary central nervous system lymphoma: case study and literature review.
Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care.
Anti-neurofascin antibody in patients with combined central and peripheral demyelination.
Epidemiology of Multiple Sclerosis in Iran: A Systematic Review.
Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.
CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation.
Disease course heterogeneity and OCT in multiple sclerosis.
An adaptive clinical trials procedure for a sensitive subgroup examined in the multiple sclerosis context.
NADH-dehydrogenase Type-2 Suppresses Irreversible Visual Loss and Neurodegeneration in the EAE Animal Model of MS.
Effect of light finger touch in balance control of individuals with multiple sclerosis.
Twenty years of experience on stem cell transplantation in iran.
Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
Effects of isoxazolo-pyridinone 7e, a potent activator of the nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.
Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
Correction to Imidazol-1-ylethylindazole Voltage-Gated Sodium Channel Ligands Are Neuroprotective during Optic Neuritis in a Mouse Model of Multiple Sclerosis.
Do Patients With Multiple Sclerosis Show Different Daily Physical Activity Patterns From Healthy Individuals?
Targeting FcRn for therapy: From live cell imaging to in vivo studies in mice.
Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin.
Disclosing a misdiagnosis of multiple sclerosis: do no harm?
Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab.
A critical role for interleukin-1β in the progression of autoimmune diseases.
Delayed Recovery of Leg Fatigue Symptoms Following a Maximal Exercise Session in People With Multiple Sclerosis.

Pages